-
-
-
-
-
-
-
Inovio Pharmaceuticals (INO) PT Lowered to $2.50 at H.C. Wainwright
-
-
-
-
-
-
-
INOVIO BLA for rare respiratory disease treatment accepted by FDA
-
-
-
-
-
-
-
INOVIO begins rolling submission for INO-3107 treatment approval
-
-
-
-
-
-
-
Inovio Pharma (INO) Announces Proposed Share Offering
-
-
-
-
-
-
-
Inovio Pharma (INO): Clinical and Immunological Results from Phase 1/2 Study of INO-3107 as a Treatment for Recurrent Respiratory Papillomatosis Published in Nature Communications
-
-
-
-
-
-
-
Inovio Pharmaceuticals (INO) PT Lowered to $6 at RBC Capital
-
-
-
-
-
-
-
H.C. Wainwright Reiterates Buy Rating on Inovio Pharmaceuticals (INO)
-
483,098 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


